"Perhaps it is not showing due to the embargo". “...Dr. Lin intends to reference unlabeled/unapproved uses of drugs or products in her presentation.”
Embargo DetailsWith the exception of those selected for the official SABCS press program, abstracts will be posted to the SABCS website November 17, 2020. Embargoes on those abstracts lift as soon as they are available online. Abstracts selected for the press program will post online and lift embargo throughout the Symposium.
Tuesday 8 December should reveal further updated details regarding - Paxalisib (GDC-0084) in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases.
Regards.
KZA Price at posting:
$1.41 Sentiment: Buy Disclosure: Held
